BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10436095)

  • 1. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.
    Grotta JC; Chiu D; Lu M; Patel S; Levine SR; Tilley BC; Brott TG; Haley EC; Lyden PD; Kothari R; Frankel M; Lewandowski CA; Libman R; Kwiatkowski T; Broderick JP; Marler JR; Corrigan J; Huff S; Mitsias P; Talati S; Tanne D
    Stroke; 1999 Aug; 30(8):1528-33. PubMed ID: 10436095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
    Stroke; 2000 Dec; 31(12):2912-9. PubMed ID: 11108748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravenous thrombolysis patients with acute ischemic stroke--the analysis of the 100 cases. Part II. Neuroimaging, the analysis of hemorrhagic complications and deaths].
    Sobolewski P; Sledzińska M; Szczuchniak W; Grzesik M; Sobota A; Hatalska-Zerebiec R
    Przegl Lek; 2012; 69(6):242-6. PubMed ID: 23094436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The validity and reliability of signs of early infarction on CT in acute ischaemic stroke.
    Dippel DW; Du Ry van Beest Holle M; van Kooten F; Koudstaal PJ
    Neuroradiology; 2000 Sep; 42(9):629-33. PubMed ID: 11071432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study.
    Demchuk AM; Hill MD; Barber PA; Silver B; Patel SC; Levine SR;
    Stroke; 2005 Oct; 36(10):2110-5. PubMed ID: 16166579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperdense sylvian fissure MCA "dot" sign: A CT marker of acute ischemia.
    Barber PA; Demchuk AM; Hudon ME; Pexman JH; Hill MD; Buchan AM
    Stroke; 2001 Jan; 32(1):84-8. PubMed ID: 11136919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.
    Stroke; 1997 Nov; 28(11):2109-18. PubMed ID: 9368550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.
    Patel SC; Levine SR; Tilley BC; Grotta JC; Lu M; Frankel M; Haley EC; Brott TG; Broderick JP; Horowitz S; Lyden PD; Lewandowski CA; Marler JR; Welch KM;
    JAMA; 2001 Dec; 286(22):2830-8. PubMed ID: 11735758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data.
    Trouillas P; Nighoghossian N; Getenet JC; Riche G; Neuschwander P; Froment JC; Turjman F; Jin JX; Malicier D; Fournier G; Gabry AL; Ledoux X; Derex L; Berthezène Y; Adeleine P; Xie J; Ffrench P; Dechavanne M
    Stroke; 1996 May; 27(5):882-90. PubMed ID: 8623108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eligibility determination for intravenous thrombolysis based on radiology interpretation report of the head CT scan in patients with acute ischemic stroke.
    Hassan AE; Majidi S; Janjua NA; Chaudhry SA; Tekle WG; Grigoryan M; Qureshi AI
    J Neuroimaging; 2014; 24(4):349-53. PubMed ID: 24015702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of early CT signs of >1/3 middle cerebral artery infarctions : interrater reliability and sensitivity of CT interpretation by physicians involved in acute stroke care.
    Kalafut MA; Schriger DL; Saver JL; Starkman S
    Stroke; 2000 Jul; 31(7):1667-71. PubMed ID: 10884471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors.
    Trouillas P; Nighoghossian N; Derex L; Adeleine P; Honnorat J; Neuschwander P; Riche G; Getenet JC; Li W; Froment JC; Turjman F; Malicier D; Fournier G; Gabry AL; Ledoux X; Berthezène Y; Ffrench P; Dechavanne M
    Stroke; 1998 Dec; 29(12):2529-40. PubMed ID: 9836764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II.
    Dzialowski I; Hill MD; Coutts SB; Demchuk AM; Kent DM; Wunderlich O; von Kummer R
    Stroke; 2006 Apr; 37(4):973-8. PubMed ID: 16497977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pooled assessment of computed tomography interpretation by vascular neurologists in the STRokE DOC telestroke network.
    Spokoyny I; Raman R; Ernstrom K; Demaerschalk BM; Lyden PD; Hemmen TM; Guzik AK; Chen JY; Meyer BC
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):511-5. PubMed ID: 23697761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
    Rhoney DH; Coplin WM; Lin Y; Frankel M; Lyden PD; Levine SR
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute stroke: usefulness of early CT findings before thrombolytic therapy.
    von Kummer R; Allen KL; Holle R; Bozzao L; Bastianello S; Manelfe C; Bluhmki E; Ringleb P; Meier DH; Hacke W
    Radiology; 1997 Nov; 205(2):327-33. PubMed ID: 9356611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of triphasic perfusion computed tomography for intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Lee KH; Lee SJ; Cho SJ; Na DG; Byun HS; Kim YB; Song HJ; Jin IS; Chung CS
    Arch Neurol; 2000 Jul; 57(7):1000-8. PubMed ID: 10891982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypodensity of >1/3 middle cerebral artery territory versus Alberta Stroke Programme Early CT Score (ASPECTS): comparison of two methods of quantitative evaluation of early CT changes in hyperacute ischemic stroke in the community setting.
    Mak HK; Yau KK; Khong PL; Ching AS; Cheng PW; Au-Yeung PK; Pang PK; Wong KC; Chan BP;
    Stroke; 2003 May; 34(5):1194-6. PubMed ID: 12690213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.